As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/28/22  Revance Therapeutics, Inc.        S-8         2/28/22    5:197K                                                            
 2/28/22  Revance Therapeutics, Inc.        10-K       12/31/21  106:12M                                                             
 2/28/22  Revance Therapeutics, Inc.        8-K:2,5,9   2/25/22   11:353K                                                            

____________
¹	Filing/Form Types:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-K	Annual Report — Form 10-K.
	S-8	Registration Statement – Securities for an Employee Benefit Plan — Form S-8.